Dalbavancin Pharmacokinetics in an 18-Month-Old Child Undergoing Extracorporeal Membrane Oxygenation
This pharmacokinetic alteration in dalbavancin disposition during ECMO may lead to suboptimal drug exposure, possibly impairing the ability to maintain PK/PD efficacy of dalbavancin over time.
Authors
- Andrea Moscatelli (ORCID: https://orcid.org/0000-0002-7839-317X)
- Francesca Mattioli (ORCID: https://orcid.org/0000-0001-8460-0262)
- Giammarco Baiardi (ORCID: https://orcid.org/0000-0001-7809-077X)
- Elio Castagnola (ORCID: https://orcid.org/0000-0002-5336-8429)
- Alessia Cafaro (ORCID: https://orcid.org/0000-0003-1132-1267)
- Marcello Mariani (ORCID: https://orcid.org/0000-0003-2989-7301)
- Giuliana Cangemi (ORCID: https://orcid.org/0000-0001-6847-5983)
- Maria Beatrice Damasio (ORCID: https://orcid.org/0000-0001-6737-1090)
- Alessio Mesini (ORCID: https://orcid.org/0000-0003-0593-4112)
- Elisabetta Lampugnani (ORCID: https://orcid.org/0000-0003-4150-3977)
Institutions
- Istituto Giannina Gaslini (IT)
- Ente Ospedaliero Ospedali Galliera (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Genoa (IT)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1097/ftd.0000000000001325
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00